[3H]-YM-09151-2 binding sites in human brain postmortem

Neurochemistry International

Volumn 55, Issue 7, 2009, Pages 643-647

  Marazziti, Donatella ^a   Baroni, Stefano ^a   Masala, Irene ^a   Giannaccini, Gino ^a   Betti, Laura ^a   Palego, Lionella ^a   Dell'Osso, Mario Catena ^a   Consoli, Giorgio ^a   Castagna, Maura ^a   Lucacchini, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

3H YM 09151 2; D2 like receptors; D4 receptors; Dopamine; Hippocampus; Human brain; Prefrontal cortex; Striatum

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; EMONAPRIDE; RACLOPRIDE; SIGMA OPIATE RECEPTOR; SULPIRIDE; TRITIUM;

ADULT; ARTICLE; AUTOPSY; BINDING ASSAY; BINDING SITE; BRAIN HOMOGENATE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

AGED; BENZAMIDES; BINDING SITES; BRAIN CHEMISTRY; DATA INTERPRETATION, STATISTICAL; DOPAMINE ANTAGONISTS; FEMALE; HIPPOCAMPUS; HUMANS; KINETICS; MALE; MIDDLE AGED; NEOSTRIATUM; POSTMORTEM CHANGES; PREFRONTAL CORTEX; PROPYLAMINES; RACLOPRIDE; RECEPTORS, DOPAMINE D4; RECEPTORS, SIGMA; SULPIRIDE;

EID: 69549088018     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.06.005     Document Type: Article

References (38)

1. Assie M.B., Consul-Denjean N., Koek W., and Newman-Tancredi A. Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex. Pharmacology 75 (2005) 63-68
2. Bristow L.J., Patel S., Ragan C.I., Ridgill M., Saywell K.L., and Tricklebank M.D. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. J. Pharmacol. Exp. Ther. 283 December (3) (1997) 1256-1263
3. 50) of an enzymatic-reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
4. Civelli O., Bunzow J.R., Grandy D.K., Zhou Q.Y., and Van Tol H.H. Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 207 (1991) 277-286
5. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148 (1991) 1474-1486
6. De La Garza R., and Madras B.K. [(3)H]PNU-101958, a D(4) dopamine receptor probe, accumulates in prefrontal cortex and hippocampus of non-human primate brain. Synapse 37 (2000) 232-244
7. Engelborghs S., Vloeberghs E., Le Bastard N., Van Buggenhout M., Marien P., Somers N., Nagels G., Pickut B.A., and De Deyn P.P. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem. Int. 52 May (6) (2008) 1052-1060
8. Florijn W.J., Tarazi F.I., and Creese I. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. J. Pharmacol. Exp. Ther. 280 (1997) 561-569
9. Franekova V., Baliova M., and Jursky F. Truncation of human dopamine transporter by protease calpain. Neurochem. Int. 52 June (8) (2008) 1436-1441
10. Hagberg G., Gefvert O., Bergström M., Wieselgren I.M., Lindström L., Wiesel F.A., and Långström B. N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Res. 82 (1998) 147-160
11. Helmeste D.M., and Tang S.W. Dopamine D4 receptors. Jpn. J. Pharmacol. 82 (2000) 1-14
12. Helmeste D.M., Tang S.W., Bunney Jr. W.E., Potkin S.G., and Jones E.G. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains. Eur. J. Pharmacol. 314 (1996) 3-5
13. Helmeste D.M., Tang S.W., Li M., and Fang H. Multiple [3H]-nemonapride binding sites in calf brain. Naunyn Schmiedebergs Arch. Pharmacol. 356 (1997) 17-21
14. Khan Z.U., Gutiérrez A., Martín R., Peñafiel A., Rivera A., and De La Calle A. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J. Comp. Neurol. 402 (1998) 353-371
15. Kempf L., Hussain N., and Potash J.B. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int. Rev. Psychiatry 17 (2005) 9-19
16. Lahti R.A., Roberts R.C., Cochrane E.V., Primus R.J., Gallager D.W., Conley R.R., and Tamminga C.A. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Mol. Psychiatry 3 (1998) 528-533
17. Lanau F., Brockhaus M., Pink J.R., Franchet C., Wildt-Perinic D., Goepfert C., Probst A., and Hartman D.S. Development and characterization of antibodies against the N terminus of the human dopamine D4 receptor. J. Neurochem. 69 (1997) 2169-2178
18. Lee S.P., O'Dowd B.F., Ng G.Y., Varghese G., Akil H., Mansour A., Nguyen T., and George S.R. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol. Pharmacol. 58 (2000) 120-128
19. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., and Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1387-1392
20. Maletic V., Robinson M., Oakes T., Iyengar S., Ball S.G., and Russell J. Neurobiology of depression: an integrated view of key findings. Int. J. Clin. Pract. 61 (2007) 2030-2040
21. Marazziti D., Lucacchini A., Baroni S., Betti L., Catena M., Giannaccini G., Dell'Osso B., Masala I., Mungai F., and Dell'Osso L. Presence of D4 dopamine receptors in human prefrontal cortex: a postmortem study. Rev. Bras. Psiquiatr. 29 (2007) 148-152
22. Matsumoto M., Hidaka K., Tada S., Tasaki Y., and Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J. Neurochem. 66 (1996) 915-919
23. McPherson G.A. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J. Pharmacol. Methods 14 (1985) 213-228
24. Meador-Woodruff J.H., Damask S.P., Wang J., Haroutunian V., Davis K.L., and Watson S.J. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15 (1996) 17-29
25. Meltzer H.Y. An overview of the mechanism of action of clozapine. J. Clin. Psychiatry 55 (1994) 47-52
26. Muglia P., Petronis A., Mundo E., Lander S., Cate T., and Kennedy J.L. Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Mol. Psychiatry 7 (2002) 860-866
27. Mulcrone J., and Kerwin R.W. No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics. Neurosci. Lett. 219 (1996) 163-166
28. Oak J.N., Oldenhof J., and Van Tol H.H. The dopamine D(4) receptor: one decade of research. Eur. J. Pharmacol. 29 (2000) 303-327
29. Primus R.J., Thurkauf A., Xu J., Yevich E., McInerney S., Shaw K., Tallman J.F., and Gallagher D.W. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. J. Pharmacol. Exp. Ther. 282 (1997) 1020-1027
30. Roberts D.A., Balderson D., Pickering-Brown S.M., Deakin J.F., and Owen F. The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls. Schizophr. Res. 20 (1996) 171-174
31. Seeman P., Guan H.C., and Van Tol H.H. Dopamine D4 receptors elevated in schizophrenia. Nature 365 (1993) 441-445
32. Seeman P., Guan H.C., Van Tol H.H., and Niznik H.B. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse 14 (1993) 247-253
33. Stefanis N.C., Bresnick J.N., Kerwin R.W., Schofield W.N., and McAllister G. Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Brain Res. Mol. Brain Res. 53 (1998) 112-119
34. Tang S.W., Helmeste D.M., Fang H., Li M., Vu R., Bunney Jr. W., Potkin S., and Jones E.G. Differential labelling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains. Brain Res. 765 (1997) 7-12
35. Tarazi F.I., and Baldessarini R.J. Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol. Psychiatry 4 (1999) 529-538
36. Tarazi F.I., Campbell A., Yeghiayan S.K., and Baldessarini R.J. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1, D2-, and D4-like receptors. Neuroscience 83 (1998) 169-176
37. Tarazi F.I., Zhang K., and Baldessarini R.J. Dopamine D4 receptors: beyond schizophrenia. J. Recept. Signal Transduct. Res. 24 (2004) 131-147
38. Ujike H., Akiyama K., and Kuroda S. [3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypes. Neuroreport 10 (1996) 1057-1061